The exclusion of older patients from clinical trials regarding heart failure. Causes and consequences
Older subjects are commonly excluded from clinical trials, that are the gold standard to assess the efficacy and safety of new drugs and non pharmacological therapies. The consequence is the lack of evidence about the optimal drug therapy in this population, who makes the highest consumption of drug...
Saved in:
Published in | Recenti progressi in medicina Vol. 103; no. 3; p. 103 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | Italian |
Published |
Italy
01.03.2012
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Be the first to leave a comment!